Watchlist Price Alert

Selecta Biosciences Inc. (SELB)

NASDAQ: SELB · Real-Time Price · USD

0.88

-0.08 (-8.12%)

At close: Nov 13, 2023, 9:00 PM

Selecta Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-219.71M	35.38M	-25.69M	-68.88M	-55.35M	-65.34M	-65.32M	-36.21M
Depreciation & Amortization	764K	1.29M	1.25M	734K	2.03M	975K	750K	802K
Stock-Based Compensation	n/a	11.19M	7.72M	5.42M	5.16M	5.71M	4.08M	2.05M
Other Working Capital	-3.56M	-63.79M	-45.5M	94.46M	337K	-265K	9.3M	9.91M
Other Non-Cash Items	160.7M	-19.11M	2.13M	1.75M	402K	449K	1.33M	471K
Deferred Income Tax	-19M	n/a	2.4M	10.85M	806K	-182K	942K	208K
Change in Working Capital	3.56M	-60.38M	-48.19M	85M	-4.48M	-781K	7.12M	13.2M
Operating Cash Flow	-51.16M	-31.63M	-60.38M	34.88M	-51.44M	-59.16M	-52.04M	-19.68M
Capital Expenditures	-206K	-1.2M	-1.08M	-815K	-47K	-884K	-733K	-586K
Cash Acquisitions	n/a	13.8M	2M	n/a	n/a	n/a	-60.15M	-6.9M
Purchase of Investments	n/a	-33.5M	-32.45M	n/a	-18.19M	-15.6M	-61.53M	-28.42M
Sales Maturities Of Investments	28.25M	19.7M	16.4M	n/a	18.34M	41.66M	60.16M	6.9M
Other Investing Acitivies	6.56M	-13.8M	-2M	74K	122K	99K	4K	2K
Investing Cash Flow	34.61M	-15M	-17.14M	-741K	229K	25.27M	-2.1M	-22.1M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	231K	n/a	n/a	184K	28K	n/a	180K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-13.14M	39.22M	52.9M	14.43M	105.04M	697K	66.02M	67.66M
Financial Cash Flow	-13.14M	39.22M	52.9M	14.43M	105.04M	697K	66.02M	67.66M
Net Cash Flow	-29.75M	-7.4M	-24.63M	48.51M	53.87M	-33.34M	11.97M	26.32M
Free Cash Flow	-51.37M	-32.83M	-61.47M	34.07M	-51.48M	-60.05M	-52.77M	-20.27M